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ABSTRACT 
  
 The goal of this study was to create pre-formed neural spheroid networks (NSN) 
on a polydimethyl siloxane (PDMS) concave microwell array for eventual implantation 
into the rat brain. Recent studies have shown that stem cells have great potential in 
treating various neurological insults of the central nervous system, ranging from 
traumatic brain and spinal cord injury, to neurodegenerative disorders. However, the use 
of stem cell lines in research are controversial due to the method of obtaining cells, in 
their formation of teratomas and degeneration into cancer cells, their non-specific 
differentiation, and  lastly in their inability to control the location of neural connections. 
A novel approach to address this issue utilizes pre-formed neural networks consisting of 
neural spheroids on polymer scaffolds for the implantation into the rat brain. Yet, it was 
observed that the cylindrical shape of the wells hindered the transfer process. This study 
aimed to overcome the lack of neural spheroid network detachment by utilizing concave 
well structures, using a simple method developed in this laboratory.  
  vi 
Primary neurons were isolated from pregnant Sprague Dawley rats at 16 ~ 17 
days of gestation. Isolated neurons were cultured in PDMS wells with a concave structure 
and interconnected by rounded micro channels. It was reported previously that a concave 
structure enabled an easier and more efficient formation of spheroids, not to mention the 
ease in extraction of spheroid cells. Various studies have demonstrated the effectiveness 
of guidance channels in promoting neurite growth. Therefore, micro channels were 
integrated in the micro array design, and served as a guidance conduit to enhance neurite 
growth, and by association, spheroid interconnection.  
The primary neurons formed a spheroid structure after 3 days, upon which they 
began to sprout new neurites. By day 8, neurite connections peaked. Spheroid diameter 
underwent an initial decrease then stabilized on day 2. Various well diameters (300~700 
um) and channel lengths (1.5 x diameter ~ 3 x diameter) were evaluated, with a 300 um 
well diameter and 450 um center-to-center channel length found to be optimal. The 
completed network was assessed for interconnection using calcium imaging and showed 
coordinated calcium signals between the neural spheroids. The network was then 
successfully transferred to a collagen matrigel and cultured for a week. The methodology 
showed an improvement in the transfer of networks, with about a 90% extraction rate. 
The viability of the NSN on the matrigel was assessed using a Live/Dead assay, and cells 
were found to have greater than 95% viability. The optimal hydrophilicity was 
determined for neurite extension and transfer of NSNs onto the matrigel. It was found 
that an incubation time between 4~6 hours was optimal.  
  vii 
Future studies will involve the implantation of the NSN into the rat brain.  
Additionally, the use of neural progenitor and stem cell lines may provide an autologous 
source of cells which are immunocompatible with the host. In particular, marrow stromal 
cells are interesting in that they may also address the ethical concerns. A long term goal 
is to refine the methodology and apply this research to enable studies in the treatment of 
patients suffering from spinal cord injury and other neurodegenerative disorders.    
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INTRODUCTION 
 
Neural tissue engineering is an approach utilized to recover lost sections of the 
nervous system. Although there have been successful cases of tissue engineering 
approaches, such as in skin grafts, damage to the nervous system provides an intriguing 
challenge to biomedical researchers due to its complexity thereby presenting an ongoing 
challenge to successfully implement treatments for neuronal disorders. Current treatment 
of neuronal disorders consists predominately of management of symptoms, necessitating 
the need for alternative treatment methods [1]. Stem cell therapy is gaining widespread 
attention due to the pluripotent nature of the cells and its capability in replenishing 
deficient cell populations of the brain [2-4]. However, stem cell therapy is subject to 
several obstacles, most notably the controversy in obtaining cell samples, non-specific 
differentiation and formation of teratomas, and cell graft survival [5-7]. Implantable pre-
formed neural networks grown in physiologically compatible scaffolds may offer a 
possible alternative to stem cell treatment of nervous system injury [8]. This study will 
begin with a brief overview of neural tissue engineering and related studies. Current 
causes of known nervous system insult will be inspected as well as relevant therapeutic 
research in the area, particularly of tissue engineering strategies. Finally, we will 
introduce a novel methodology to culture primary rat cortical neurons in concave 
microwells for prospective applications in the treatment of nervous system injury. 
 Tissue engineering is defined as an interdisciplinary field that combines aspects 
of life sciences and engineering, and applies this approach to develop strategies that 
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restore, maintain, or replace function of tissues or organs [9]. Neural tissue engineering is 
a specialized field of tissue engineering focusing on restoring function to the nervous 
system through grafts or implantable scaffolds to repair diseased or damaged neural 
tissue or cells of the central nervous system (CNS) and peripheral nervous system (PNS) 
[10]. For the PNS, the autologous nerve graft is considered the gold standard of treatment 
[11]. In the CNS however, due to the different physiological and pathological responses 
to neural insult, a different method of treatment is required. It is known that due to the 
lack of Schwann cells in the CNS, neurite damage is replaced by fibrous scar tissue 
mediated by glial cells [12]. Neural insult to the CNS is varied in the causes and 
symptoms, and can be a consequence of either traumatic brain injury (TBI), 
neurodegenerative disorders, or spinal cord injury (SCI). In the context of this experiment, 
neural insult will be limited to those that can be addressed by neural tissue engineering. 
TBI is considered one of the leading causes of disability and morbidity worldwide 
among young adults, with an increasing number of patients suffering from TBIs due to 
motor vehicle accidents in low and middle income countries [13]. The aging population 
and increased use of firearms and explosive devices are also contributing to a higher rate 
of TBI. The annual incidence of mild TBI is estimated to be 10 million worldwide, 
depending on severity and classification schemes [14]. In the United States, it is 
estimated that 235,000 individuals are hospitalized for non-fatal TBI annually [15]. TBI 
is defined as an external injury sustained by external physical forces due to rapid 
acceleration/deceleration, impact, blast waves, or penetration by a projectile. Primary 
brain damage usually results in shearing of white-matter tracts, focal contusions, 
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haematomas, and microscopic damages ranging from microporation of membranes to 
leaky ion channels. Onset of secondary damage may develop over several hours after the 
injury to days, and include inflammatory responses and calcium-mediated damage [13]. 
Current treatment revolves around stabilizing patients, preventing further injury, and 
rehabilitation. However, TBI leads to long-term disability, and it is estimated that there 
are 3.3 million disabled patients in the US alone [16].  
Parkinson’s disease (PD) is a common neurologic disorder, and affects 
approximately 1% of individuals over 60 years [17]. PD is characterized by hallmark 
neuronal cell loss of dopaminergic neurons within the substantia nigra. The symptoms of 
PD include rigidity, tremor, and loss of postural reflexes. The exact causes are unknown, 
however, it is believed that the presence of Lewy bodies contribute to apoptosis of 
dopaminergic neurons [18]. Others have attributed PD to viral infections or 
environmental factors, with a small minority of cases attributed to a genetic defect 
[19,20]. Administration of L-Dopa is a common treatment, but is prone to numerous side 
effects and dopamine dysregulation syndrome in the long run [21].  
Huntington’s disease (HD) is another well-studied neurological disorder, and is 
characterized by polyglutamate expansions in the Huntingtin protein. HD is considered a 
heritable disease as it is caused by an autosomal dominant mutation in the Huntingtin 
gene. HD initially affects the GABA neurons of the basal ganglia, and exhibits symptoms 
of progressive physiological, motor, cognitive, and psychological deterioration [22]. The 
World Health Organization (WHO) estimates that 5~7 people per 100,000 in Western 
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countries are affected by HD [23]. There is currently no treatment, and patients 
eventually become completely incapacitated.  
Spinal cord injury (SCI) is believed to affect over 250,000 people in the US. [24]. 
SCI is caused by physical trauma to the spinal cord and presents with various symptoms. 
SCI usually results in paralysis and downstream loss of function in specific areas, 
depending on which section of the spinal cord was injured. As the CNS environment 
prohibits regeneration of damaged neural connections, treatment options are limited, and 
patients usually require intense rehabilitation and experience life-long functional 
impairment.   
The above neurological insults, and lack of current treatment options, demonstrate 
the need for further therapeutic research. Cell transplantation studies, especially of stem 
cell lines, have shown great promise in addressing these disorders. Stem cells are 
pluripotent, and have the capability to differentiate into any type of cell, including those 
of the nervous system. Embryonic stem cells (ESC) have been explored as a possible 
source for treating PD. Human embryonic stem cells (hESC) were differentiated into 
dopamine-producing midbrain neurons in vitro using bone marrow and aorta-gonad-
mesonephros-derived stromal feeder cells [25]. Keirstead et al. demonstrated 
remyelination and restoration of locomotion from hESC-derived oligodendrocyte 
progenitor cells in a spinal cord injury model in rats [26]. Induced pluripotent stem cells 
(iPSC) offer an interesting alternative to ESCs. iPSCs are obtained from adult skin cells 
by exposing them to specific factors and restoring pluripotency [27]. Hu et al. showed 
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that human iPSCs followed a similar differentiation route as hESCs, but displayed poor 
efficiency and increased variability [28]. Research on both cell types has yet to be 
translated into successful clinical trials that prove their efficacy. Additionally, these cells 
are prone to forming teratomas and have issues with immunoincompatibility, not to 
mention the ethical concerns regarding the origin of hESCs [5-7, 29].  
Adult stem cells have been gaining increased consideration as an autologous 
source of multipotent cells that address many of the ethical issues facing the use of ESCs. 
These cells show similarity to ESCs, but also have the advantage of ease of isolation, 
self-renewal, and multipotent properties [1]. Table 1 summarizes studies conducted on 
adult stem cells. In particular, bone marrow stromal cells (MSC) show great promise, and 
have been studied extensively. MSCs can be found in the stroma of the bone marrow and 
are a heterogeneous cell population which includes stem and progenitor cells [1]. The 
strongly adherent property of MSCs allows for easy isolation [30]. MSCs have been 
studied in the treatment of TBI. Implantation of human MSCs in rats led to improved 
functional benefits; however, only about 10% of MSCs transdifferentiated into neuronal 
cells [31]. Therefore, it was assumed that growth factors released by the MSCs 
contributed to functional recovery by enhancing glial, neuronal, and vascular remodeling 
[32]. In vitro studies have shown the possibility of MSCs to differentiate toward 
dopaminergic phenotypes [33, 34]. Yet, it is likely that MSCs confer a neuroprotective 
effect through release of neurotrophic factors [35]. Although MSCs have great potential, 
they are subject to poor cell survival and their neuroregenerative properties have yet to be 
fully elucidated.  
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Disease 
Model 
Cell 
Type 
Cell 
Origin 
Functional Benefits Reference 
HD 
MSC 
Rat 
Mouse 
Mouse 
Rat 
Migration of MSCs to striatum 
Decrease striatum atrophy 
Reduction behavioral deficits 
Neuroprotective Effect 
 
Sadan, Shemesh et al. 2008 
Amin, Reza et al. 2008 
Dey et al. 2010 
Moraes et al. 2012 
Adult 
NSC 
Rat 
Rat 
Formation functional 
GABAergic and glutamatergic 
synapses 
Preservation striatal tissue and 
behavioral function 
 
Toda et al. 2000 
Roberts et al. 2006 
PD 
MSC 
Rat 
Rat 
Mouse 
Improved dopamine production 
Preservation dopaminergic 
neurons 
Improvement basic motor 
behavior 
 
Danielyan et al. 2011 
Glavaski-Joksimovic et al. 
2010 
Kang et al. 2011 
iPSC 
Rat 
Rat 
Human 
Integration and survival of cells 
Reduction motor asymmetry 
Successful differentiation into 
dopaminergic neurons and 
improved behavioral deficit in 
rats 
Cai et al. 2010 
Hargus et al. 2010 
Swistowski, Zeng et al. 2010 
Adult 
NSC 
Mouse Reduction rotational deficit Ziavra et al. 2012 
 
 
The application of tissue engineering strategies including the use of biocompatible 
scaffolds offers the possibility of enhancing stem cell survival.  Scaffolds in a tissue 
engineering context must be biodegradable and biocompatible, and must minimize 
immune response while conferring longevity to implanted cells [36]. Porosity is also an 
important factor as nutrients must be able to pass through. Biologically compatible 
Table 1. Adult Stem Cell Therapies for Various Neural Degenerative Disorders 
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scaffolds have been shown to increase the viability of implanted stem cell grafts. In a TBI 
mouse model, MSCs seeded on a collagen gel-based scaffold, and injected in the lesion, 
led to a decrease in the lesion volume and improved spatial learning and sensorimotor 
function [37]. A biomimetic scaffold integrating laminin, and seeded with mouse ESCs 
resulted in improved migratory potential and process extension in a PD model [38]. 
Recent developments have led to a more advanced biomimetic scaffold that increased the 
in vitro viability of human MSCs in a polyethylene glycol gel [39]. In short, the 
combination of cell transplant therapy and tissue engineering approaches, utilizing 
biologically compatible scaffolds, have become the paradigm in neural tissue engineering.  
 The treatment of neural insult, whether from disease or physical injury, has seen 
vast improvements in the past decade. Ongoing research has used induced pluripotent 
stem cells (IPS), embryonic stem cells (ESC), and marrow stromal cells (MSC), which 
have provided a ground breaking way of addressing neural pathologies such as 
Parkinson’s disease and Huntington’s disease [40-43]. Stem cell research has shown great 
promise in treating these neurological disorders. However, they are limited in their ability 
to selectively create neural networks, as the neurites are prone to randomly creating 
undesirable neural connections [8]. Although fetal nerve grafts have been employed with 
some degree of success, the grafts are unable to cover long distances, not to mention the 
ethical concerns regarding the origin of the grafts [44-46]. It is also not clear at this point 
whether the stem cells form new synapses or that they stimulate the production of trophic 
factors and glial cells such as astrocytes or oligodendrocytes, which aid in the 
rejuvenation of pre-existing neural networks [47]. Kato-Negishi et al. have proposed a 
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novel approach in addressing this issue by creating pre-formed neural networks 
consisting of neurospheroids on polymer scaffolds for the implantation into the brain [8]. 
However, it was observed that there was a lack of neural network transfer due to the use 
of cylindrical wells (Figure 1). It is believed that an angled structure increases adherence 
of cells to the edges of the wells, and thus diminishes the capacity of neural network 
transfer.  
 
 
 
 
 
 
 
Previous experiments have shown that spheroids are easily dislodged from concave wells 
with the slightest of physical forces (Jeong; unpublished data). Also, several studies have 
shown that guidance channels enhance the directional sprouting of neurites [48-50]. We 
propose a novel method of improving transfer efficiency and neurite interconnection by 
using concave wells interconnected by rounded guidance channels that act as conduits for 
the purpose of forming neural networks. The results may lead to an improvement in the 
Figure 1. Lack of neural spheroid transfer and neurite formation in cylindrical wells. 
(Figure amended from Kato-Negishi et al., 2010)  
Incomplete spheroid transfer 
Incomplete neurite formation 
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transfer efficiency of neural networks, and also more complete neurite formation due to 
improved physical cues from the microchannels. This research may be applicable in 
transplanting neural networks into the injured brain, and further the spinal cord. Future 
studies will involve growing and differentiating stem cell lines in the array for eventual 
transplantation. Use of MSCs may provide an autologous supply of cells, while being 
considerably easier to isolate and addressing any ethical concerns.  
 
SPECIFIC AIMS 
This study aims to address the problem of lack of detachment of neural spheroid 
networks by utilizing concave microwells as opposed to cylindrical wells, using a simple 
technique developed by Jeong et al [51]. Neural spheroids grown in cylindrical wells 
have a semi-spherical shape due to the adherence of the spheroid to the well bottom. The 
semi-spherical shape may compromise the detachment of the NSNs due to this adherence. 
Previous research has shown that spheroids cultured in concave wells maintained a full 
spherical shape (Figure 2), and were easily dislodged, even with the slightest of physical 
stimuli. Research on neurite extension has shown the viability of using microchannels as 
physical guidance cues that enhance directional neurite formation. We hypothesize that 
the use of concave microwells will lead to fewer adherences of spheroids, and improve 
the transfer of NSNs. Additionally, the integration of rounded microchannels, which 
serve as a conduit for guiding neurites between the spheroids, can possibly enhance 
neurite interconnection. We propose that this method will improve the formation of 
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neurites as well as transfer of NSNs for the purpose of transplantation into the brain. 
Further research may allow for the culture of stem cell lines, and potential applications in 
cell replacement therapy for the brain and spinal cord. 
 
 
 Figure 2. SEM image of a neural spheroid (Yoon-Jung 
Choi, 2011;  Used with permission). 
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METHODS 
Design of Microwell Array 
A microwell array was fabricated using conventional soft lithography techniques. Briefly, 
a microwell array with well diameters between 300~700 um in 200 um increments was 
designed using AutoCad (Autodesk, San Rafael, California). Channel lengths had a 
center-to-center length of 1.5 x diameter (d), 2d, 2.5d, and 3d. A photoresist film (Nepco, 
Seoul, S. Korea) was printed for use in the fabrication of the array. SU-8 was spin-coated 
onto a silicon wafer, then soft and hard baked according to manufacturer specifications. 
The photoresist film was aligned with the wafer and exposed to UV light at 350 nm using 
a MDA-400 aligner (Midas System, Daejon, S. Korea). The SU-8 underwent post-
exposure baking at 65 °C for 1 minute, and 95 °C based on SU-8 thickness. The SU-8 
was developed to fabricate a master mold on a silicon wafer.  
Fabrication of PDMS Concave Microwells 
Polydimethyl siloxane (PDMS; Sigma-Aldrich, St. Louis, MO) was mixed at a 10:1 ratio 
(prepolymer:curing agent) and placed in a dessicator. The PDMS prepolymer was poured 
onto the SU-8 mold and baked in an incubator at 80 °C for two hours (Figure 3). The 
dried PDMS was detached from the wafer in methanol solution. The concave structure 
was produced according to Jeong et al [51]. Briefly, PDMS prepolymer was poured into 
the wells of the base mold, and placed in a dessicator to eliminate any bubbles. Excess 
PDMS was raked out using a 1 mL pipette tip, and allowed to dry in the incubator at 
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80 °C for 2 hours (fig. 3). The surface tension of the PDMS induced a meniscus shape, 
and formed a concave well as the prepolymer solidified.  
 
  
 
 
 
 
 
 
 
Figure 3. Schematic diagram of concave well fabrication. PDMS prepolymer was poured onto 
an initial layer of base PDMS cylindrical mold; excess PDMS was raked out using a cylindrical 
apparatus and formed a meniscus shape due to the surface tension of PDMS.  
 
Scanning Electron Microscopy (SEM) 
Microwell arrays were mounted onto a specimen stub with double-sided graphite tape, 
sputter-coated with palladium alloy, and observed under a scanning electron microscope 
(JEOL Ltd, Tokyo, Japan) (Figure 4).  
Microchannel 
Microwell 
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         c  
 
 
 
 
 
 
 
Isolation of Primary Neurons 
Primary neurons were prepared as previously described [52]. Briefly, pregnant Sprague-
Dawley rats (DBL. Seoul, South Korea) at 16~17 days of gestation were euthanized 
using CO2. The cortices of the fetuses were isolated using a pair of microscissors and 
suspended in cold Hank’s buffered saline solution (HBSS). The mixture was trypsinized 
with TrypSE (Invitrogen) at a ratio of 3:1 (HBSS:Trypsin) for 15 minutes in a water bath 
Figure 4. SEM images of PDMS concave microwell array. a) shows a top view of the wells 
b) close-up of wells at 75x; c) front view of wells showing concave shape 
c 
a b 
a                                                             b 
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at 37 °C. The mixture was washed twice with HBSS then finally washed with bare 
neurobasal media (Gibco). The cortices were fragmented using a pipette and passed 
through a 0.22 um nylon filter (Gibco). Cells were cultured in neural basal media 
supplemented with B-27 (Gibco), PenStrep (Gibco), and glutamate (Gibco). All 
procedures adhered to the standards of the Institutional Review Board of Korea 
University. 
Creation of Neural Spheroids 
Cell viability was assessed using trypan blue (Invitrogen), and seeded at a density of 5.0 
x 106 cells/mL in the concave wells. Cells generally had a viability of 62%. The cells 
were allowed to settle into the wells in an incubator at 37 °C, 5% CO2, and 80% 
humidity for 30 minutes. Excess cells were washed away with bare media (Figure 5). 
Nerve growth factor (Prospec) was added at a concentration of 1 ng/mL. After the final 
wash, seeded cells were observed under an inverted phase contrast microscope (EVOS, 
AMG, USA). Cells were incubated at 37 °C, 5% CO2, and 80% humidity for 13 days. 
Media was changed every two days. 
 
a 
  15 
 
 
 
 
 
 
 
 
 
 
Figure 5. Schematic diagram of cell seeding. (a) Cells were seeded at a density of 5.0 x 10
6
 
cells/mL and incubated for 30 mins. (b) and (c) Excess cells that did not settle in the wells were 
washed out with media; cells within the wells were not washed away. 
 
Matrigel Transfer 
Matrigel (Invitrogen) was added to the wells after removal of media. A rounded glass 
slide was placed as a cover. The wells were placed upright and incubated at 37 °C for 16 
hours, while immersed in supplemented media. The slide was carefully removed with a 
small volume of media and placed in a petri dish and observed under a microscope. 
b. Seeding neuron cells c. Removing cells in channel 
a. Cell seeding illustration 
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Live/Dead Assay 
Cell viability was assessed with the Live/Dead assay. Briefly, cells were incubated with 
ethidium/calcein (Live/Dead Assay; Invitrogen) in PBS for 30 minutes at 37 °C, 5% CO2 
and 80% humidity. Cells were washed with PBS three times then observed under a 
fluorescent microscope (Axio Observer.A1. Carl Zeiss, Inc).   
Calcium Imaging 
Calcium fluxes were measured as previously described [8]. Briefly, 1 mM Fluo-4/AM 
(Invitrogen) in DMSO was added to cells in a basal salt solution (BSS) consisting of 20 
mM HEPES-NaOH (pH 7.4), 1.8 mM CaCl2, 5.4 mM KCl, 5.5 mM glucose, and 130 
mM NaCl. Cells were incubated for 60 mins at 37 °C for one hour. Cells were washed 
three times with BSS, then observed under an inverted fluorescent microscope (Axio 
Observer.A1. Carl Zeiss, Inc). Images were captured at 50 ms intervals for 100 frames. 
Immunofluorescent Imaging 
Cells were fixed with 4% paraformaldehyde in 0.1% Triton X-100 in PBS solution. Cells 
were rinsed with 0.1% FBS in PBS solution three times, then incubated overnight at 4 °C 
with primary rabbit polyclonal anti-neurofilament antibodies (Abcam). The cells were 
rinsed and incubated at 4°C for 90 min with Alexa Fluor 488-conjugated or Alexa Fluor 
594-conjugated anti-rabbit IgG (Invitrogen) secondary antibodies, as appropriate. The 
cells were then incubated with DAPI (4,6-diamidino-2-phenylindole), and confocal 
microscopic images were obtained (Olympus, Japan). 
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Statistical Analysis 
All statistical analyses were performed using SPSS (IBM, New York, USA). Values are 
indicated as the mean±SE (standard error of the mean). A student T-test was used to 
measure statistical significance of experimental groups, where p< 0.05 was considered as 
statistically significant. 
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RESULTS 
 
Spheroid Formation and Neurite Interconnection 
The optimal level of spheroid formation and neurite interconnection was assessed 
utilizing the concave microwell array. Well diameters were 300 um, 500um, and 700 um. 
Channel length was varied between 1.5d to 3d in 0.5 increments, where d is the diameter 
of the wells, and length was determined by the distance from the center of each well to 
the next well. Previous research has shown that the concave microwell array is an 
efficient platform for culturing cell spheroids of uniform size and shape [51]. 
Characteristics of spheroids, including the size, shape, and viability was assessed over a 
13 day period. Figure 6 shows phase contrast images of spheroid formation in the control 
group (cylindrical wells) with a 300 um diameter, 450 um channel length (center-to-
center) microwell array over a 13 day period. There was a lack of neurite extension in the 
cylindrical wells after 13 days. Spheroids grown in concave wells, with definite neurite 
growth interconnecting the wells are shown in Figure 7. Figure 8 compares the neurite 
formation in the 300 um concave wells with varying microchannel length at day 13. 
Neurites seem to sprout from day 3, and peak at day 8, after which there is little change. 
It was found that a smaller well diameter and channel length generally led to the more 
efficient formation of spheroids and interconnection of neurites. Therefore, the 300 um 
diameter well with 450 um channel length was found to possess the most optimal 
dimensions for culturing neural spheroid networks. 
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Day 0 Day 2 Day 4 
Day 6 Day 8 Day 10 
Day 12 Day 13 
Figure 6. Spheroid formation in 300 um diameter cylindrical microwell 
array over 13 days. Microchannel length was 450 um (center-center). 
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Day 3 Day 5 Day 6 
Day 7 Day 8 Day 9 
Day 12 
 
Day 13 Day 11 
 
Figure 7. Spheroid formation in 300 um diameter concave microwell array 
over 13 days. Microchannel length was 450 um (center-center). 
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Change in Diameter of Spheroid over Time 
To assess the change in spheroid formation over a 13 day period, spheroid diameters 
were measured for the three varying well sizes using ImageJ [53]. Figure 9 depicts the 
changes in spheroid diameter for 300, 500, and 700 um wells over a 13 day period. The 
Figure 8. Comparison of neurite formation in 300 um concave microwell 
arrays with varying channel length at day 13. Channels were a) 450 um, b) 
600 um, c) 750 um, and d) 900 um. 
a) 450 um channel 
 
b) 600 um channel 
 
c) 750 um channel 
 
d) 900 um channel 
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spheroid diameter in the 300 um concave wells started off around 256 ± 4.1 um and 
stabilized by day 2 with a diameter of 210.2 ± 3.7 um. In contrast, the spheroids in the 
500 and 700 um concave wells stabilized after 6 days, with a decrease from initial values 
of 384.5 ± 3.7 and 622.2 ± 0.8 um, to 306.1 ± 3.6 and 350.8 ± 0.8 um respectively.   
 
 
 
 
 
 
 
 
 
 
 
 
Assessment of Neurite Formation 
Neurite formation was characterized by immunofluorescent staining to determine the 
extent of neurite interconnection. Figure 10 shows two different NSN groups: (b) and (d). 
Neurites were stained with anti-neural filament (MAP2) and is displayed in green, while 
blue is a DAPI stain of the neucleus. Neurites formed between the spheroids in the 
Figure 9. Change in spheroid diameter over 13 days for 3 different well 
sizes. Bars represent standard error. The distance is the length of the 
microchannels. N= 3 each for each well size group. 
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concave wells. In contrast, there was no neurite interconnection in the cylindrical wells 
(c).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Calcium Imaging 
In order to determine the degree of interconnection of the neurites in the NSN, we 
performed a calcium imaging experiment to measure the calcium flux. Figure 11 shows a 
group of four neural spheroids interconnected by neurites. We used a pseudocolor 
scheme in Metamorph software (Molecular Devices) to better visualize the fluxes. 
a 
b 
d c 
Figure 10. Immunofluorescent Images of NSN.  a) phase contrast image of a 
NSN; b) confocal image of same NSN; c) fluorescent image NSN in cylindrical 
wells; d) fluorescent image of NSN in concave wells. 
a 
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Fluorescence intensity of the calcium spikes follow the color-coded bar, where red 
characterizes the highest intensity and purple lowest. Spheres 1 and 2 showed 
coordinated calcium fluxes as did spheres 3 and 4 (Figure11 (a) and (b)). Intensity 
profiles were plotted on a graph; spheres 1 and 2 showed similar profiles, while spheres 3 
and 4 showed coordination, indicating neurite interconnection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
c 
Figure 11. Calcium imaging of a NSN. ∆F/Fo = 0.015; 5s. a) a pseudocolor 
scheme of 4 spheroids b) increased fluorescent intensity of spheroids 3 and 4   
c) a graph plot of fluorescent intensity of the spheroids. Sphere 1 and 2, 3 and 4 
showed coordinated Ca fluxes. ∆F/Fo is the momentary fluorescent intensity 
and 5s is the total duration of the recording; image capture time interval was 50 
ms for 100 frames. The vertical color bar represents fluorescent intensity. 
a 
b 
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Matrigel Transfer 
In order to determine the ideal conditions for transfer of NSNs onto the matrigel, we 
varied the incubation time and orientation – up-right or upside-down –, as well as the 
residual media in the wells, of the NSN in the concave microwells. Figure 12 compares 
the different conditional settings and the resulting transfer of NSNs onto the matrigel. It 
was found that NSN transfer onto the matrigel occurred more readily when the wells 
were oriented up-right with a small amount of media. An incubation time exceeding 16 
hours was found to be optimal. Figure13 shows a Live/Dead assay of a successful 
transfer of a NSN onto the matrigel after 16 hours. The spheroids maintained a high 
viability after their transfer onto the matrigel (green) and maintained a grid-like 
configuration. A small degree of necrosis (red) was visible in the middle of the spheroids. 
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Figure 12. Varying conditional settings of matrigel transfer of NSNs. 
Right side-up orientation showed the best transfer, while upside-down 
orientation resulted in lack of transfer. Further, the presence of a small 
amount of media improved transfer rates. 
Matrigel Wells after transfer 
Condition 1: 
Right side-up 
w/o  media  
 
Condition 2: 
Right side-up 
/w media  
 
Condition 3: 
 Upside-
down /w 
media  
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Optimal Hydrophilicity for Neurite Extension and Matrigel Transfer 
It is known that cell adherence is a necessity in order for neurites to extend their 
processes. Rogers et al. achieved cell adherence through the coating of extracellular 
matrix (ECM) proteins laminin and fibronectin, which have become the common ECM 
material to enable cell adherence on hydrophobic surfaces [54]. However, doing so would 
hamper the transfer of the NSN onto matrigel. Since the surface of PDMS is normally 
hydrophobic, we attempted to control the neurite extension and transfer by applying 
oxygen plasma onto the surface of the wells to induce a hydrophilic charge. A previous 
study has elucidated the characteristics of hydrophilic charge on the surface of PDMS 
[55]. Hydrophilicity was controlled by incubating the wells at 80 °C for different periods 
of time to hasten hydrophobic recovery. Incubation time varied from 30 minutes to 7 
hours, with the control having no exposure to oxygen plasma. Figure 14 shows a 
comparison of wells at day 0 with varying hydrophilicity. An incubation time of 30 
Figure 13. Live/dead image of successful NSN transfer onto matrigel. 
Green represents live cells while red indicates necrosis.  
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minutes showed the highest degree of cell adherence, with a decreasing amount of cells 
adhering with higher incubation time. The control showed the best spheroid detachment, 
while maintaining the original configuration; neurite formation was minimal. Stronger 
hydrophilicity (3 hours incubation time) showed moderate detachment; however, the 
spheroid shape was flattened due to strong adherence of cells to the substrate. The 7 hour 
incubation demonstrated the ideal combination of neurite interconnection and spheroid 
detachment. Figures 14-16 show the wells and matrigel after transfer for the control, 3 
hour incubation, and 7 hour incubation groups. Figure 17 summarizes the three groups in 
terms of neurite extension, detachment, and maintenance of original shape. One of the 
wells in the 7 hour group was lost after 8 days due to contamination. 
 
 
 
 
 
 
 
 
 
 
 
 Figure 14. Phase contrast images of 2 wells of the control group. The first 
row is an image at day 0; 2
nd
 row is at day 11; and the last row is after 
transfer onto matrigel.  
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Figure 15. Phase contrast images of 2 wells after 3 hours of incubation. 
The first row is an image at day 0; 2
nd
 row is at day 11; and the last row is 
after transfer onto matrigel.  
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Figure 16. Phase contrast images of 2 wells after 7 hours of incubation. 
The first row is an image at day 0; 2
nd
 row is at day 11; and the last row is 
after transfer onto matrigel.  
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Figure 17. A bar graph summarizing the neurite extension, transfer 
rate, and pattern retainment of the 3 groups. Bars represent standard 
error; n =2 for each group.  
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DISCUSSION 
 
In this study, we demonstrated the feasibility of forming neural spheroid networks 
in a concave microwell array for eventual implantation into the rat brain. Cell spheroids 
are conventional 3-dimensional cell culture models, which in contrast to 2-dimensional 
cell cultures, more accurately mimic the in vivo environment [56-58]. In the native 
cellular environment, 3-dimensional cell–cell and cell–ECM interactions are pivotal in 
creating a communication network that maintains the specificity and homeostasis of the 
tissue [59]. Previously, Jeong et al. have demonstrated the viability of using concave 
microwells to produce homogeneous spheroid-shaped embryoid bodies. It was also 
noticed that spheroids were easily dislodged from the concave wells with the slightest of 
physical stimuli (Jeong GS, unpublished data). Therefore, it was a goal of this study to 
culture homogenously-sized neural spheroids in a concave microwell array that might 
allow for convenient extraction.  
Kato-Negishi et al. demonstrated the neural stamping method by culturing NSNs 
in a cylindrical well array, and transferred the NSNs onto various substrates. We noticed 
that there was a lack of spheroid transfer, as well as incomplete neurite formation (Figure 
1). We suspected that cylindrical wells used by the aforementioned researchers had 
definite edges to which the spheroids would attach to, thus hindering the detachment and 
transfer process of NSNs. In order to solve the problem of incomplete neurite connections, 
we studied previous research on microchannels and its effects on neurite growth [48-50]. 
It was shown that the implementation of microchannels acted as a physical guidance cue 
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that encouraged the growth of neurites along the channels. Therefore, we designed 
concave well structures with interconnecting rounded microchannels. Various attempts 
were made to optimize the diameter and distance of the microchannels. It was found that 
smaller wells and shorter microchannel distances improved the formation of spheroids 
and neurite interconnection, corroborating the results from Kato-Negishi. It is believed 
that the proximity of the shorter microchannels allowed for better interconnection 
between the spheroids through a shorter distance required for biochemical cell signaling. 
As a result, we used the wells with a 300 um diameter and a microchannel length of 150 
um (450 um center-center). Although Kato-Negishi’s group found that a 100 um diameter 
with a 100 um distance between wells was optimal, our group was able to achieve 300 
um spheroids with minimal central necrosis. Additionally, the integration of 
microchannels allowed for robust neurite formation, even in distances that exceeded 100 
um.  
It must be noted that there were other differences in our protocol compared to 
Kato-Negishi’s group. We used neural basal media supplemented with B-27 and nerve 
growth factor (NGF) as opposed to using Dulbecco’s modified eagle media (DMEM) 
supplemented with F-12 and B-27. Neural basal media is known to suppress the 
proliferation of glial cells, necessitating the need for an external source of biochemical 
growth factors, hence the use of NGF. In constrast, Kato-Negishi’s group relied on the 
proliferation of glial cells as a source of NGF, but was unable to achieve successful NSNs 
in wells that exceeded 100 um. We suspect that minimal growth of glial cells and a 
higher concentration of neurons permitted for a more efficient supply of nutrients to 
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primary neurons within the neural spheroids, allowing for larger well diameters with 
minimal central necrosis. Additionally, the protocol was able to forego the use of a 
supplement (F-12) without compromising the viability of the neural spheroids.  
In order to visualize the neurites, we performed immunofluorescent imaging using 
fluorescent and confocal microscopy. Cultures were stained with an antibody for 
neurofilament, which stains the microtubules within the neurites. It was confirmed that 
neurites originated from the spheroids and interconnected with adjacent cells. Indeed, 
they interconnected robustly in the absence of glial cell proliferation, which is in stark 
contrast to Kato-Negishi’s group. It has been previously mentioned that glial cells are a 
prerequisite to axonal and dendritic extension [60-63]. It is possible that NGF acted as a 
mitogen on the glial cells, although the media (Neural Basal media) contains anti-mitotic 
factors that inhibit glial cell proliferation. We believe that the dose of NGF used (1 
ng/mL) may have been sufficient to overcome the inhibitory effects of the media. A 
previous study has shown that growth factors can have a mitogenic effect on Müller glial 
cells of the retina [64]. Diaz-Cintra et al. found that NGF promoted the maturation of 
neurons and glial cells in a fetal graft [65]. Further experiments will have to be conducted 
to confirm this. 
Calcium imaging, which is a common method of visualizing transient 
biochemical fluxes, was used to assess the degree of neurite interconnection between the 
spheroids within the network. As noted in Kato-Negishi’s study, the spheroids exhibited 
spontaneous bursts of calcium fluxes of an oscillatory nature, confirming the presence of 
functional synapses. This was captured by detecting the fluorescent intensity of the bursts 
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by a high speed camera, and plotting the temporal intensity on a graph. Adjacent 
spheroids showed coordinated burst of calcium fluxes, which shows that they were 
interconnected with each other.  
Although a primary goal of this study was to improve the growth of neurites, 
preliminary experiments resulted in inconsistencies. Whereas the very first experiment 
resulted in robust neurite growth, successive experiments failed to replicate the previous 
results. It is known that neurons require some degree of adhesion for successful neurite 
growth as the outer membrane consists of a slightly hydrophilic charge [66]. PDMS is a 
hydrophobic polymer, and in general does not encourage the growth of neurties. The use 
of oxygen plasma is a common method of bonding PDMS units. Oxygen plasma was also 
used in this experiment in the fabrication of wells, particularly in bonding PDMS 
perimeters for usable wells. Therefore, we hypothesized that the inconsistencies in the 
neurite growth from the preliminary experiments resulted from residual hydrophilic 
charge conferred by the oxygen plasma. Consequently, we conducted an experiment to 
determine the optimal amount of hydrophilic charge that allows for maximal neurite 
growth. We subjected the surface of the microwell array to oxygen plasma for 60 s, then 
incubated the wells at 80 °C to control the amount of hydrophilicty. Kim et al. have 
shown that PDMS exposed to oxygen plasma slowly recovers its hydrophobic state in air. 
This process of recovery was found to accelerate at higher temperatures. It was found that 
3 hours had too much of a hydrophilic charge as to inhibit the transfer process of the 
NSNs onto the matrigel, as well as flattened spheroids that were elongated in shape due 
to stronger adherence. However, the 3 hour group did have the best formation of neurites, 
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confirming the importance of cell adherence. The 7 hour group displayed little difference 
from the control group, which was not exposed to oxygen plasma, and therefore had a 
completely hydrophobic surface. We surmised that the optimal level may lie between 3 
and 7 hours, and incubated the rest of the experimental group for 5 hours, which 
generally resulted in adequate neurite growth.  
As the surface of the brain is very delicate, we considered possible ways to avoid 
the direct application of PDMS onto the brain surface. Considering that Kato-Negishi’s 
group incubated the NSNs on various substrates for up to 24 hours, we viewed this 
method as impractical due to the amount of time required and possibility of damaging the 
surface of the brain. Kato-Negishi’s group also treated the surface of the substrates with 
polyethylenimine (PEI) to enhance the transfer of the NSN. Again, we considered this as 
infeasible during implantation. It is not mentioned in Kato-negishi’s paper as to the use of 
PEI during the implantation process onto the rat brain. It is entirely possible that they 
ignored this step, which may account for the lack of NSN transfer. As an alternative, we 
considered the possibility of using a hydrogel intermediate. 
The current paradigm for neural tissue engineering relies on scaffolding materials 
to support the implanted cells. Previously, hydrogel scaffolds have been shown to 
improve the viability of implanted cells while being biocompatible [67]. Therefore, we 
tried two hydrogels: collagen type I gel and matrigel. Collagen I hydrogel was found to 
be too soft and transfer was not successful due to the inability of the gel to capture the 
spheroids. In contrast, matrigel, which consists of collagen type IV, was found to be an 
efficient medium to transfer the NSNs onto. Matrigel is slightly more firm than collagen 
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type I, and was able to effectively capture the spheroids while maintaining the grid-like 
configuration of the NSN. It was also noticed that the orientation of the wells after 
addition of matrigel had a significant effect on the transfer rates. When the wells were 
placed upside-down, transfer was significantly impeded. We suspect that the spheroids do 
not settle to the ground entirely, but are slightly adrift due to a lower density than the 
media. When placed upside-down, the spheroids tended to float and would be closer to 
the well bottom than the interface between the matrigel and residual media. The loose 
configuration of the spheroids is noticeable when handling the wells for observation, 
where the occasional shaking motion of the hand may dislodge the spheroids from the 
wells. Therefore, a right side-up configuration and an incubation time of 16 hours was 
sufficient to maximize transfer of NSNs onto the matrigel. 
Additional experiments will have to be conducted in concave wells with a 100 um 
diameter and 100 um interconnecting microchannels to make a more accurate comparison. 
Continuing problems with the fabrication of such dimensions, mostly due to the two-
layer structure required to integrate the microchannels, resulted in difficulty in aligning 
the two layers, and prevented the effective fabrication of the 100 um concave microwell 
array. This is more a matter of inexperience than the actual difficulty in fabricating such a 
structure. Further efforts will be made to perfect the procedure as to enable a more 
definitive comparison of the two methods. However, it should be noted that we achieved 
a fair degree of success using the 300 um concave wells, with improved neurite formation 
and transfer efficiency while using a different media (neural basal media); not to mention 
the omission of any F-12 supplement. Future studies will include the application of the 
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matrigel/NSN onto the rat cortical brain and growth of stem cell lines, particularly MSCs, 
to differentiate into neurons. The presence of glial cells within the spheroids will have to 
be detected to ascertain the effects of glial cell proliferation on neural spheroids. 
Additional scaffolding materials may be explored, especially of smart thermal responsive 
material such as poly (n-isopropylacrylamide; PNIPAM), which may allow the transfer of 
intact NSNs without an intermediate hydrogel component.  
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